iBio Inc.
IBIO | NASDAQ
$1.25
-$0.01 (-0.79%)
Sep 22, 2026, 11:11 AM ET · Market open
Market Data
Market Cap $19.89M
Enterprise Value $-65.95M
Beta 1.29
Average Volume 885.44K
Shares Outstanding (Diluted) 104.06M
Shares Change YoY 533.6%
Institutional Ownership 16.24%
Exchange NASDAQ
ISIN US4510337086
Price Performance
Price Change 1M -12.5%
Price Change 3M -23.6%
Price Change 6M -42.2%
Price Change YTD -37.6%
Price Change 1Y 55.4%
Price Change 3Y -79.7%
Price Change 5Y -99.8%
1M CAGR (ann.) -10.6%
1Y CAGR (ann.) 44.8%
5Y CAGR (ann.) -70.7%
All-Time CAGR -36.5%
Valuation
PE Ratio -3.82
Forward PE N/A
PEG Ratio -0.02
Forward PEG -0.07
PS Ratio 198.95
Forward PS 795.80
PB Ratio 0.23
P/FCF Ratio -0.84
P/Adj. FCF Ratio -0.79
P/OCF Ratio -5.73
EV/Sales -659.46
EV/EBIT 2.00
EV/EBITDA 2.04
EV/FCF 2.77
Earnings Yield -26.2%
FCF Yield -119.6%
Adj. FCF Yield -126.5%
Financial Health
Net Cash $87.49M
Total Debt $2.2M
Cash & Short-Term Investments $56.4M
Total Assets $99.11M
Current Ratio 7.85
Quick Ratio 7.85
Debt / Equity Ratio 0.03
Debt / EBITDA -0.07
Debt / FCF -0.09
OCF / Debt -10.56
Interest Coverage -663.04
Altman Z-Score -4.39
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -35141.0%
EBITDA Margin -32345.0%
Net Profit Margin -33044.0%
FCF Margin -23796.0%
Adj. FCF Margin -25169.0%
SBC / Revenue 1373.0%
SBC Impact (per share) -5.8%
Returns
Return on Assets -33.3%
Return on Equity -47.9%
Return on Invested Capital -40.0%
Return on Capital Employed -40.2%
Return on Tangible Assets -34.0%
Historical Growth (CAGR)
Revenue CAGR 3Y -25.9%
Revenue CAGR 5Y -46.9%
Revenue CAGR 10Y -20.1%
EPS CAGR 3Y 122.4%
EPS CAGR 5Y 93.5%
EPS CAGR 10Y 23.7%
FCF CAGR 3Y -13.0%
FCF CAGR 5Y 25.1%
FCF CAGR 10Y -4.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 4
EPS Growth Next 3Y -40.4%
Revenue Growth Next 3Y -30.7%
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.06
EPS Growth Est (next Q) -45.5%
Revenue Est (next Q) $20K
Revenue Growth Est (next Q) -80.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $5
Price Target Upside 296.8%
Cash Flow
Operating Cash Flow $-23.22M
Free Cash Flow $-23.8M
Adj. Free Cash Flow $-25.17M
FCF Per Share -$0.23
OCF Per Share -$0.22
OCF/S Ratio -23218.0%
Income Statement
Revenue $100K
Gross Profit $100K
Operating Income $-35.14M
EBITDA $-32.35M
Net Income $-33.04M
EPS (Diluted) -$0.33
Revenue / Employee $5K
Profit / Employee $-1.65M
Employees 20
Add to Watchlist
Select watchlists to add or remove IBIO